Latest Operational Cash Flow News

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.

Freelancer Limited has reported a landmark half-year profit, driven by strong revenue growth, AI project demand, and a major NASA contract win. Operational advances across its platforms underscore a promising outlook.

Advanced Braking Technology Ltd (ABT) posted a robust FY25 with sales up 27% and underlying profits nearly doubling, driven by strong international demand and innovation milestones.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Murray Cod Australia reports a near tripling of biomass and strong sales growth in Q4 FY25, while advancing key certifications and expanding market reach.

Resolute Mining reported solid Q2 2025 gold production of 75,962 ounces and maintained its full-year guidance, supported by strategic project acquisitions and steady progress across key West African assets.

Resolute Mining delivered steady gold production in Q2 2025 while progressing its strategic expansion with the Doropo acquisition and promising Bantaco resource estimates. The company remains on track for its 2025 guidance despite operational challenges.

Buru Energy advances its Rafael Gas Project in Western Australia with a focus on sustainable growth, targeting a final investment decision in 2026 and production start in 2028. The project aims to supply local power generation with trucked LNG and condensate, replacing costly imports.

Li-S Energy has secured a strategic defence collaboration, advanced its Pegasus I drone testing, and commissioned Australia's first lithium metal foil production line, all while maintaining a solid cash position.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.